ImmunoDOT Borrelia (Lyme)

ImmunoDOT Borrelia (Lyme)


Contact us for more information.

The ImmunoDOT Borrelia test, intended as a screening test for Lyme disease, combines purified borrelia proteins enriched with recombinant P39 (a specific B. burgdorferi protein) 2 and an absorption step to minimize cross-reactivity without compromising sensitivity.

Available in 25 or 100 tests

Borrelia_Lyme_Package_Insert.pdf Borrelia_Lyme_Package_Insert.pdf 

ImmunoDOT is an easy-to-use, visually interpreted, rapid-test format, dipstick ELISA that allows individual patients to be tested for multiple parameters simultaneously. Up to five or six different tests may be completed simultaneously on a single patient specimen, making it ideal for users who require fast, flexible and reliable diagnostic tests in a single patient format. ImmunoDOT is a sophisticated test format which is a multiparameter, nitrocellulose ELISA with sensitivities and specificities similar to reference method western blots. This format also equals or surpasses traditional ELISA formats for sensitivity and specificity

The potential customers for ImmunoDOT include:

  • Labs preferring rapid turnaround rather than batching
  • Medium and small-sized hospitals
  • Clinics
  • Group practice office laboratories
  • Any lab preferring rapid results turnaround

The only expense for ImmunoDOT equipment is the modestly priced dry bath workstation designed to hold the disposable reaction vessels included with the kits.